ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,203Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 1107

$1.51M Total Retail Price of All Prescriptions

Rank: 25 out of 1107

1,100 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 1,100 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 1,100 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 18,758 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
OMEPRAZOLE 1,157 769 1 4
PRAVASTATIN SODIUM 878 625 2 12
HYDROCODONE-ACETAMINOPHEN 797 516 S3 3 1
LISINOPRIL 752 557 4 2
LEVOTHYROXINE SODIUM 746 531 5 3
FUROSEMIDE 729 545 6 7
MELOXICAM 725 543 7 25
SIMVASTATIN 690 487 8 5
METOPROLOL TARTRATE 582 408 9 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 553 310 10 24
METFORMIN HCL 478 305 11 8
GABAPENTIN 475 239 12 9
POTASSIUM CHLORIDE 462 355 13 14
AMLODIPINE BESYLATE 458 374 14 6
ATORVASTATIN CALCIUM 339 265 15 13
ATENOLOL 317 244 16 19
PROAIR HFA 275 158 17 37
WARFARIN SODIUM 270 209 18 15
CITALOPRAM HBR 261 145 19 17
NEXIUM 255 139 20 18
LOSARTAN POTASSIUM 251 231 21 29
CRESTOR 242 144 22 23
ZOLPIDEM TARTRATE 238 133 23 22
METFORMIN HCL ER 232 172 24 58
SERTRALINE HCL 231 143 25 20
HYDROCHLOROTHIAZIDE 226 172 26 11
GLIMEPIRIDE 223 167 27 43
FLUTICASONE PROPIONATE 223 155 27 38
TAMSULOSIN HCL 221 182 29 30
METOPROLOL SUCCINATE 214 175 30 16
LOVASTATIN 212 148 31 55
SYMBICORT 209 143 32 124
ALLOPURINOL 207 156 33 36
PANTOPRAZOLE SODIUM 190 149 34 30
TIZANIDINE HCL 182 85 35 73
CEFUROXIME 179 111 36 157
AMOXICILLIN 178 122 37 90
ETODOLAC 177 83 38 210
CIPROFLOXACIN HCL 173 116 39 59
FLUOXETINE HCL 171 86 40 47
CLOPIDOGREL 163 96 41 28
RANITIDINE HCL 162 84 42 21
AZITHROMYCIN 160 98 43 35
PROMETHAZINE HCL 154 38 R 44 44
TRAMADOL HCL 151 92 45 26
CELEBREX 150 98 46 85
OXYCODONE HCL-ACETAMINOPHEN 149 71 S2 47 93
LEVOFLOXACIN 147 94 48 71
FINASTERIDE 146 142 49 130
MECLIZINE HCL 146 121 49 114
TRAZODONE HCL 140 73 51 33
PAROXETINE HCL 137 81 52 45
VENTOLIN HFA 129 72 53 97
DIOVAN 127 109 54 51
POLYETHYLENE GLYCOL 3350 126 96 55 46
CYCLOBENZAPRINE HCL 121 60 R 56 56
NAMENDA 120 87 57 42
OXYBUTYNIN CHLORIDE 119 99 58 171
DOXAZOSIN MESYLATE 114 110 59 92
LOSARTAN-HYDROCHLOROTHIAZIDE 110 95 60 66
CARVEDILOL 110 96 60 27
ALPRAZOLAM 109 21 62 87
LORAZEPAM 109 84 62 155
LANTUS SOLOSTAR 108 81 64 129
TRIAMTERENE-HYDROCHLOROTHIAZID 106 72 65 185
AMITRIPTYLINE HCL 105 62 R 66 48
DONEPEZIL HCL 102 88 67 32
LANTUS 102 83 67 49
PLAVIX 102 66 67 39
PREDNISONE 100 78 70 40
DIOVAN HCT 99 82 71 106
GEMFIBROZIL 99 52 71 107
GLYBURIDE 98 70 R 73 68
CEFDINIR 97 67 74 163
ALENDRONATE SODIUM 96 67 75 41
CYMBALTA 95 46 76 50
ADVAIR DISKUS 91 63 77 54
PREMARIN 91 29 R 77 149
OXYCODONE-ACETAMINOPHEN 89 58 S2 79 104
FENOFIBRATE 89 55 79 67
SPIRONOLACTONE 88 72 81 72
JANUVIA 88 28 81 60
DOXEPIN HCL 87 18 83 180
TRIAMCINOLONE ACETONIDE 84 49 84 137
RISPERIDONE 84 35 84 79
VERAPAMIL ER 84 78 84 113
ENDOCET 83 28 S2 87 91
DICLOFENAC SODIUM 81 45 88 74
BUPROPION HCL SR 79 38 89 190
CEPHALEXIN 78 48 90 81
DILTIAZEM 24HR CD 77 67 91 126
ROPINIROLE HCL 75 51 92 69
BYSTOLIC 74 68 93 138
DICYCLOMINE HCL 74 24 93 208
PRIMIDONE 74 55 93 251
NAPROXEN 73 31 96 80
TOPIRAMATE 73 0 96 160
GLIPIZIDE 72 53 98 64
METOCLOPRAMIDE HCL 72 28 98 116
INSULIN SYRINGE 71 40 100 78
AMLODIPINE BESYLATE-BENAZEPRIL 71 55 100 77
DILTIAZEM ER 70 62 102 139
CLONIDINE HCL 70 41 102 53
DIAZEPAM 70 28 102 254
CLOTRIMAZOLE-BETAMETHASONE 70 57 102 198
CARBIDOPA-LEVODOPA 69 52 106 122
NOVOLOG 68 31 107 127
FLUCONAZOLE 66 35 108 150
VENLAFAXINE HCL ER 65 36 109 117
COMBIVENT 65 38 109 112
LANSOPRAZOLE 65 46 109 102
SPIRIVA 63 37 112 57
ZETIA 59 54 113 76
PEN NEEDLE 59 53 113 192
METHOCARBAMOL 58 16 R 115 142
QUETIAPINE FUMARATE 57 0 116 94
BUMETANIDE 54 31 117 123
PROPRANOLOL HCL 54 51 117 134
LYRICA 54 23 117 83
VOLTAREN 54 42 117 265
ESTRADIOL 53 41 R 121 151
EVISTA 52 48 122 135
SINGULAIR 51 25 123 65
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 34 124 88
NOVOLOG FLEXPEN 50 46 124 230
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 25, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.